A detailed history of B Long Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, B Long Financial, LLC holds 14,742 shares of BMY stock, worth $690,073. This represents 0.46% of its overall portfolio holdings.

Number of Shares
14,742
Previous 14,942 1.34%
Holding current value
$690,073
Previous $692 Million 3.88%
% of portfolio
0.46%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$43.31 - $48.98 $8,662 - $9,796
-200 Reduced 1.34%
14,742 $665 Million
Q2 2025

Aug 13, 2025

BUY
$44.12 - $59.6 $43,193 - $58,348
979 Added 7.01%
14,942 $692 Million
Q1 2025

May 13, 2025

BUY
$53.9 - $63.11 $26,950 - $31,555
500 Added 3.71%
13,963 $852 Million
Q4 2024

Jan 30, 2025

BUY
$51.92 - $59.94 $698,998 - $806,972
13,463 New
13,463 $761 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track B Long Financial, LLC Portfolio

Follow B Long Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B Long Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on B Long Financial, LLC with notifications on news.